West
Virginia
|
55-0169957
|
|
(State
or other jurisdiction of incorporation or
organization)
|
(I.R.S.
Employer Identification
No.)
|
Large
accelerated filer o
|
Accelerated
filer þ
|
Non-accelerated
filer o
|
Smaller
reporting company o
|
(Do
not check if a smaller reporting company)
|
Title of Each Class of Securities to be
Registered
|
Amount to be Registered(2)
|
Proposed Maximum Price per Unit(3)
|
Proposed Maximum Aggregate Offering
Price(4)
|
Amount of Registration Fee(1)
|
City Holding Company:
|
||||
Common Stock
|
||||
Preferred Stock
|
||||
Warrants to purchase Common
Stock
|
||||
Warrants to purchase Preferred
Stock
|
||||
Units
|
||||
TOTAL:
|
$100,000,000
|
$100,000,000
|
$3,930
|
(1)
|
Estimated
in accordance with Rule 457(o) solely for the purpose of calculating the
registration fee.
|
(2)
|
Includes
such indeterminate number of shares of common stock, shares of preferred
stock, warrants to purchase common stock, warrants to purchase preferred
stock and units that City Holding Company may sell pursuant to this
Registration Statement, which may not exceed the maximum aggregate
offering price of $100,000,000. The securities registered hereunder also
include such indeterminate number of shares of common stock, preferred
stock or warrants that may be issued upon conversion, exchange or exercise
of any of the securities being registered
hereby.
|
(3)
|
Omitted
pursuant to General Instruction II.D of Form S-3. The proposed maximum
offering price per class of security will be determined from time to time
by City Holding Company in connection with, and at the time of, the
issuance by City Holding Company of the securities registered
hereunder.
|
(4)
|
In
no event will the aggregate initial offering price of the securities
issued under this Registration Statement exceed the amount registered
above or the equivalent thereof in one or more foreign currencies or
currency units.
|
We
will amend and complete the information in this prospectus. We may not
sell any of these securities or accept your offer to buy any of them until
the documentation filed with the SEC relating to these securities has been
declared “effective” by the SEC. This prospectus is not an offer to sell
these securities or our solicitation of your offer to buy these securities
in any State or other jurisdiction where that would not be permitted or
legal.
|
Page
|
||
1
|
||
1
|
||
2
|
||
3
|
||
3
|
||
3
|
||
3
|
||
4
|
||
8
|
||
10
|
||
10
|
||
12
|
||
12
|
||
12
|
|
·
|
the
Company may incur additional loan loss provision due to negative credit
quality trends in the future that may lead to a deterioration of asset
quality;
|
|
·
|
the
Company may incur increased charge-offs in the
future;
|
|
·
|
the
Company may experience increases in the default rates on previously
securitized loans that would result in impairment losses or lower the
yield on such loans;
|
|
·
|
the
Company may not continue to benefit from strong recovery efforts on
previously securitized loans resulting in impairment charges on these
assets;
|
|
·
|
the
Company could have adverse legal actions of a material
nature;
|
|
·
|
the
Company may face competitive loss of
customers;
|
|
·
|
the
Company may be unable to manage its expense
levels;
|
|
·
|
the
Company may have difficulty retaining key
employees;
|
|
·
|
changes
in the interest rate environment may have results on the Company’s
operations materially different from those anticipated by the Company’s
risk management functions;
|
|
·
|
changes
in general economic conditions and increased competition could adversely
affect the Company’s operating
results;
|
|
·
|
changes
in other regulations and government policies affecting bank holding
companies and their subsidiaries, including changes in monetary policies,
could negatively impact the Company’s operating
results;
|
|
·
|
the
Company may experience difficulties growing loan and deposit
balances;
|
|
·
|
the
current economic environment poses significant challenges for us and could
adversely affect our financial condition and results of
operations; and
|
|
·
|
the
United States government’s plan to purchase large amounts of illiquid,
mortgage-backed and other securities from financial institutions may not
be effective.
|
|
·
|
the
designation of such series and the number of shares to constitute such
series;
|
|
·
|
the
par value of the shares of such series, if
any;
|
|
·
|
the
voting rights, if any;
|
|
·
|
the
dividend rate;
|
|
·
|
whether
dividends are cumulative and, if so, the date from which dividends
cumulate;
|
|
·
|
the
payment date for dividends;
|
|
·
|
redemption
rights, the applicable redemption prices and such other conditions of
redemption;
|
|
·
|
amounts
payable to holders on our liquidation, dissolution or winding
up;
|
|
·
|
the
amount of the sinking fund, if any;
|
|
·
|
whether
the shares will be convertible or exchangeable into equity, and, if so,
the prices and terms of conversion and such other terms and conditions of
such conversion or exchange;
|
|
·
|
whether
future shares of the series or any future series or other class of stock
is subject to any restrictions, and, if so, the nature of the
restrictions;
|
|
·
|
the
conditions or restrictions, if any, upon the issuance of any additional
stock; and
|
|
·
|
any
other powers, preferences and relative, participating, optional and other
special rights, and any qualifications, limitations and restrictions
thereof.
|
|
·
|
a
public announcement that a person or group of affiliated or associated
persons has acquired or obtained a right to acquire beneficial ownership
of 15% or more of the outstanding shares of common stock of City Holding;
or
|
|
·
|
the
commencements of a tender offer or exchange offer that would result in a
person or a group becoming such an acquiring
person.
|
|
·
|
as
otherwise stated in the prospectus
supplement;
|
|
·
|
as
otherwise stated in the certificate of designation establishing such
series; or
|
|
·
|
as
required by applicable law.
|
|
·
|
the
title of the warrants;
|
|
·
|
the
aggregate number of the warrants;
|
|
·
|
the
price or prices at which the warrants will be
issued;
|
|
·
|
the
designation, amount and terms of the offered securities purchasable upon
exercise of the warrants;
|
|
·
|
if
applicable, the date on and after which the warrants and the offered
securities purchasable upon exercise of the warrants will be separately
transferable;
|
|
·
|
the
terms of the securities purchasable upon exercise of such warrants and the
procedures and conditions relating to the exercise of such
warrants;
|
|
·
|
any
provisions for adjustment of the number or amount of securities receivable
upon exercise of the warrants or the exercise price of the
warrants;
|
|
·
|
the
price or prices at which and currency or currencies in which the offered
securities purchasable upon exercise of the warrants may be
purchased;
|
|
·
|
the
date on which the right to exercise the warrants shall commence and the
date on which the right shall
expire;
|
|
·
|
if
applicable, the minimum or maximum amount of the warrants that may be
exercised at any one time;
|
|
·
|
information
with respect to book-entry procedures, if any;
and
|
|
·
|
any
other material terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants.
|
|
·
|
the
terms of the units and of any of the common stock, preferred stock and
warrants comprising the units, including whether and under what
circumstances the units may be traded
separately;
|
|
·
|
a
description of the terms of any unit agreement governing the
units;
|
|
·
|
a
description of the provisions for the payment, settlement, transfer or
exchange of the units or the securities comprising those units;
and
|
|
·
|
whether
the units will be issued fully registered or in global
form.
|
|
·
|
the
public offering price;
|
|
·
|
the
name or names of any underwriters, dealers or
agents;
|
|
·
|
the
purchase price of the securities;
|
|
·
|
the
proceeds from the sale of the securities to
us;
|
|
·
|
any
underwriting discounts, agency fees, or other compensation payable to
underwriters or agents;
|
|
·
|
any
discounts or concessions allowed or reallowed or repaid to dealers;
and
|
|
·
|
the
securities exchanges on which the securities will be listed, if
any.
|
SEC
Registration fee
|
$ | 3,930 | ||
Legal
fees and expenses
|
$ | 35,000 | * | |
Accounting
fees and expenses
|
$ | 9,500 | * | |
Other
|
$ | 50,000 | * | |
TOTAL:
|
$ | 98,430 | ||
_________________________ | ||||
* Estimate
|
||||
Exhibit
|
||
No.
|
Description
|
|
1.1
|
Form
of Underwriting Agreement*
|
|
4.1
|
Form
of certificate of designation of series of preferred
stock*
|
|
4.2
|
Form
of securities and warrant agreement*
|
|
5.1
|
Opinion
of Jackson Kelly PLLC
|
|
8.0
|
Opinion
as to certain federal income tax matters*
|
|
23.1
|
Consent
of Ernst & Young LLP
|
|
23.2
|
Consent
of Jackson Kelly PLLC (included in Exhibit 5.1)
|
|
24
|
Power
of Attorney of certain officers and directors (located on the signature
page to the Registration
Statement)
|
CITY
HOLDING COMPANY
|
||
By:
|
/s/ Charles R.
Hageboeck
|
|
Charles
R. Hageboeck
President
and Chief Executive
Officer
|
Name
|
Title
|
Date
|
||
/s/ Philip L. McLaughlin
|
Chairman
|
November
13, 2008
|
||
Philip
L. McLaughlin
|
||||
/s/ Charles R. Hageboeck
|
President,
Chief Executive Officer
|
November
13, 2008
|
||
Charles
R. Hageboeck
|
And
Director (principal executive
|
|||
Officer)
|
||||
/s/ David L. Bumgarner
|
Senior
Vice President,
|
November
13, 2008
|
||
David
L. Bumgarner
|
Chief
Financial Officer, and Principal Accounting Officer
|
|||
(principal
financial officer)
|
||||
/s/ Hugh R. Clonch
|
Director
|
November
13, 2008
|
||
Hugh
R. Clonch
|
||||
Name
|
Title
|
Date
|
||
/s/ David W. Hambrick
|
Director
|
November
13, 2008
|
||
David
W. Hambrick
|
||||
/s/ Tracy W. Hylton, II
|
Director
|
November
13, 2008
|
||
Tracy
W. Hylton, II
|
||||
/s/ Oshel B. Craigo
|
Director
|
November
13, 2008
|
||
Oshel
B. Craigo
|
||||
/s/ John R. Elliot
|
Director
|
November
13, 2008
|
||
John
R. Elliot
|
||||
/s/ William H. File, III
|
Director
|
November
13, 2008
|
||
William
H. File, III
|
||||
/s/ Robert D. Fisher
|
Director
|
November
13, 2008
|
||
Robert
D. Fisher
|
||||
/s/ Jay C. Goldman
|
Director
|
November
13, 2008
|
||
Jay
C. Goldman
|
||||
/s/ C. Dallas Kayser
|
Director
|
November
13, 2008
|
||
C.
Dallas Kayser
|
||||
/s/ James L. Rossi
|
Director
|
November
13, 2008
|
||
James
L. Rossi
|
||||
/s/ Sharon H. Rowe
|
Director
|
November
13, 2008
|
||
Sharon
H. Rowe
|
||||
/s/ Mary H. Williams
|
Director
|
November
13, 2008
|
||
Mary
H. Williams
|
Exhibit
|
||
No.
|
Description
|
|
1.1
|
Form
of Underwriting Agreement*
|
|
4.1
|
Form
of certificate of designation of series of preferred
stock*
|
|
4.2
|
Form
of securities and warrant agreement*
|
|
Opinion
of Jackson Kelly PLLC
|
||
8.0
|
Opinion
as to certain federal income tax matters*
|
|
Consent
of Ernst & Young LLP
|
||
23
|
Consent
of Jackson Kelly PLLC (included in Exhibit 5.1)
|
|
24
|
Power
of Attorney of certain officers and directors (located on the signature
page to the Registration
Statement)
|
*
|
To
be filed, as applicable, by amendment or as an exhibit to a document
incorporated by reference herein for the specific offering of securities,
if any, to which it relates.
|